Maven

SSCP

Contact Us

Recent Post

November 23rd, 2022

Hello Readers! A medical device manufacturer has to follow Conformity...

Read More
October 11th, 2022

Is your notified body asking you for a “Clinical development...

Read More
October 3rd, 2022

If a problem takes place in any medical device, questions...

Read More

Are You Looking For Medical Devices Certifications?

Contact Us

Summary of safety and clinical performance (SSCP)

The summary of safety and clinical performance (SSCP) shall be laid out with an objective of it being easy for the intended user to interpret and, if relevant, to the patient. It shall be made available to the public via Eudamed. Along with all the other technical documents, the draft of the summary of safety and clinical performance shall also be submitted to the notified body involved in the conformity assessment and shall be validated by that body. After its authentication, the notified body shall upload the summary to Eudamed. The manufacturer shall mention all the information relevant to access this summary on the label or instructions for use.

The objective of SSCP is not to:

  • provide advice on the diagnosis or treatment of particular medical conditions, nor
  • replace the instructions for use (IFU) as the main document that will be provided to ensure the safe use of a particular medical device, nor
  • replace the obligatory information on implant cards or in any other mandatory documents.
Indian-mdr-img

To which devices SSCP will be applicable and when to update?

  • The manufacturer shall draw up a summary of safety and clinical performance for implantable devices and for class III devices, other than custom-made or investigational devices.
  • For class III devices and class IIb implantable devices, other than sutures and staples etc., submit a draft SSCP which has been updated within 12 months, regardless of whether there are new data or conclusions.
  • For class IIa implantable and IIb implantable devices, such as sutures, confirm that the SSCP in EUDAMED is in alignment with the current version of the Technical Documentation (TD), or provide an updated SSCP where required.
  • Update of the SSCP at least annually as indicated

Requirements as per Regulation (EU) 2017/745

The SSCP shall include at least the following aspects:

  • The identification of the medical device and the manufacturer, including the Basic UDI-DI and, if already issued, the Single Registration Number (SRN)
  • The intended purpose of the device and any indications, contraindications and target populations
  • A description of the medical device, including a reference to previous generation(s) or variants and a description of the differences, as well as, where applicable, a description of any accessories, other devices and products, which are intended to be used in combination with the medical device
  • Possible diagnostic or therapeutic alternatives
  • Reference to any harmonized standards and Common Standards (CS) applied
  • The summary of clinical evaluation as referred to in Annex XIV in Regulation (EU) 2017/745, and relevant information on post-market clinical follow-up
  • Suggested profile and training for users
  • Information on any residual risks and any undesirable effects, warnings and precautions

FAQ:

For implantable devices and class III devices, other than custom-made or investigational
devices, the manufacturer shall draw up a summary of safety and clinical performance (SSCP)

SSCP should update annually as indicated in Regulation (EU) 2017/746

Yes. It is available on EUDAMED and on IFU/label, the manufacturer will mention the
details where SSCP is available

Connect With Us